LeadIQ logo
Learn more at LeadIQ.com

Insights

Recent Acquisition Aerie Pharmaceuticals was acquired by Alcon for approximately 770 million USD, signaling strong industry interest and potential for integration into larger ophthalmic product portfolios, which could open avenues for collaborative sales or distribution partnerships.

Innovative Focus The company specializes in first-in-class therapies targeting eye conditions such as glaucoma and dry eye, offering unique product opportunities for healthcare providers seeking advanced ophthalmic solutions.

Market Positioning With a revenue range of 25 to 50 million USD and ongoing R&D investment, Aerie is positioned as a growing player in ophthalmology, providing potential for sales expansion into niche ophthalmic markets and specialized clinics.

Technology Stack Utilizing advanced digital tools and cloud services such as AWS, SiteCatalyst, and Akamai, Aerie demonstrates a commitment to innovative tech adoption, indicating potential for collaborations in digital health solutions or data-driven product insights.

Leadership Expansion Recent leadership hires, including a Chief Medical Officer and managing director, suggest strategic growth and an emphasis on clinical research and development, opening opportunities for partnerships with clinical institutions and research organizations.

Similar companies to Aerie Pharmaceuticals

Aerie Pharmaceuticals Tech Stack

Aerie Pharmaceuticals uses 8 technology products and services including SiteCatalyst, Amazon Web Services, Drupal, and more. Explore Aerie Pharmaceuticals's tech stack below.

  • SiteCatalyst
    Analytics
  • Amazon Web Services
    Cloud Hosting
  • Drupal
    Content Management System
  • Google Fonts API
    Font Scripts
  • Backbone.js
    Javascript Frameworks
  • Modernizr
    Javascript Libraries
  • PHP
    Programming Languages
  • Akamai Bot Manager
    Security

Media & News

Aerie Pharmaceuticals's Email Address Formats

Aerie Pharmaceuticals uses at least 1 format(s):
Aerie Pharmaceuticals Email FormatsExamplePercentage
FLast@aeriepharma.comJDoe@aeriepharma.com
96%
FirstLast@aeriepharma.comJohnDoe@aeriepharma.com
1%
LastFir@aeriepharma.comDoeJoh@aeriepharma.com
2%
First-Last@aeriepharma.comJohn-Doe@aeriepharma.com
1%

Frequently Asked Questions

What is Aerie Pharmaceuticals's phone number?

Minus sign iconPlus sign icon You can contact Aerie Pharmaceuticals's main corporate office by phone at
+1-949-526-****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Aerie Pharmaceuticals's stock symbol?

Minus sign iconPlus sign iconAerie Pharmaceuticals is a publicly traded company; the company's stock symbol is AERI.

What is Aerie Pharmaceuticals's official website and social media links?

Minus sign iconPlus sign iconAerie Pharmaceuticals's official website is aeriepharma.com and has social profiles on LinkedIn.

What is Aerie Pharmaceuticals's SIC code NAICS code?

Minus sign iconPlus sign iconAerie Pharmaceuticals's SIC code is 5122 - Drugs, Drug Proprietaries, and Druggists' Sundries NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Aerie Pharmaceuticals have currently?

Minus sign iconPlus sign iconAs of December 2025, Aerie Pharmaceuticals has approximately 501 employees across 3 continents, including North AmericaEuropeAsia. Key team members include Chief Executive Officer And Board Member: R. K.Chief Compliance Officer And Corporate Counsel: C. M.Chief Commercial Officer: J. R.. Explore Aerie Pharmaceuticals's employee directory with LeadIQ.

What industry does Aerie Pharmaceuticals belong to?

Minus sign iconPlus sign iconAerie Pharmaceuticals operates in the Pharmaceutical Manufacturing industry.

What technology does Aerie Pharmaceuticals use?

Minus sign iconPlus sign iconAerie Pharmaceuticals's tech stack includes SiteCatalystAmazon Web ServicesDrupalGoogle Fonts APIBackbone.jsModernizrPHPAkamai Bot Manager.

What is Aerie Pharmaceuticals's email format?

Minus sign iconPlus sign iconAerie Pharmaceuticals's email format typically follows the pattern of FLast@aeriepharma.com. Find more Aerie Pharmaceuticals email formats with LeadIQ.

How much funding has Aerie Pharmaceuticals raised to date?

Minus sign iconPlus sign icon As of December 2025, Aerie Pharmaceuticals has raised $88M in funding. The last funding round occurred on Dec 07, 2021 for $88M.

Aerie Pharmaceuticals

Pharmaceutical ManufacturingNorth Carolina, United States501-1000 Employees

Inspiration, imagination, and innovation. We share this passion for finding new approaches to protecting vision. United by great science, deep clinical insight, and a singular focus on your ophthalmic needs, we see the possibilities ahead and invite you to join us in creating the future of eye care.

Aerie is an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, dry eye, retinal diseases and other diseases of the eye.
 
See the future of eye care with Aerie.

Section iconCompany Overview

Phone number
+1-949-526-****
Website
aeriepharma.com
SIC Code
5122 - Drugs, Drug Proprietaries, and Druggists' Sundries
Stock Symbol
AERI
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Employees
501-1000

Section iconMedia & News

Section iconFunding & Financials

  • $88M

    Aerie Pharmaceuticals has raised a total of $88M of funding over 11 rounds. Their latest funding round was raised on Dec 07, 2021 in the amount of $88M.

  • $25M$50M

    Aerie Pharmaceuticals's revenue is estimated to be in the range of $25M$50M

Section iconFunding & Financials

  • $88M

    Aerie Pharmaceuticals has raised a total of $88M of funding over 11 rounds. Their latest funding round was raised on Dec 07, 2021 in the amount of $88M.

  • $25M$50M

    Aerie Pharmaceuticals's revenue is estimated to be in the range of $25M$50M

Company Leadership

  • Stylized image of a person
    R. K.
    Chief Executive Officer And Board Member
    Phone icon
    Mobile Phone
  • Stylized image of a person
    C. M.
    Chief Compliance Officer And Corporate Counsel
    Phone icon
    Mobile Phone
  • Stylized image of a person
    J. R.
    Chief Commercial Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    C. E. D.
    Vice President & Chief Compliance Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    C. S.
    Vice President Of Finance
    Phone icon
    Mobile Phone

Employee Directory

  • Stylized image of a person
    R. K.
    Chief Executive Officer And Board Member
    Phone icon
    Mobile Phone
  • Stylized image of a person
    S. W. C.
    Co-Founder
    Phone icon
    Mobile Phone
  • Stylized image of a person
    C. S.
    Vice President Of Finance
    Phone icon
    Mobile Phone
  • Stylized image of a person
    D. M.
    Vice President
    Phone icon
    Mobile Phone
  • Stylized image of a person
    W. D.
    Vice President, Intellectual Property
    Phone icon
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.